HU166029B - - Google Patents

Info

Publication number
HU166029B
HU166029B HUTA1257A HUTA001257A HU166029B HU 166029 B HU166029 B HU 166029B HU TA1257 A HUTA1257 A HU TA1257A HU TA001257 A HUTA001257 A HU TA001257A HU 166029 B HU166029 B HU 166029B
Authority
HU
Hungary
Application number
HUTA1257A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU166029B publication Critical patent/HU166029B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HUTA1257A 1972-07-01 1973-06-01 HU166029B (en, 2012)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (en, 2012) 1972-07-01 1972-07-01

Publications (1)

Publication Number Publication Date
HU166029B true HU166029B (en, 2012) 1974-12-28

Family

ID=13311838

Family Applications (1)

Application Number Title Priority Date Filing Date
HUTA1257A HU166029B (en, 2012) 1972-07-01 1973-06-01

Country Status (15)

Country Link
US (1) US3925357A (en, 2012)
JP (1) JPS5512435B2 (en, 2012)
AT (1) AT325206B (en, 2012)
AU (1) AU469986B2 (en, 2012)
BE (1) BE801588A (en, 2012)
CA (1) CA996548A (en, 2012)
CH (1) CH573435A5 (en, 2012)
CS (1) CS168036B2 (en, 2012)
DE (1) DE2332840A1 (en, 2012)
FR (1) FR2190414B1 (en, 2012)
GB (1) GB1386566A (en, 2012)
HU (1) HU166029B (en, 2012)
NL (1) NL7308048A (en, 2012)
PL (1) PL92969B1 (en, 2012)
SE (1) SE402916B (en, 2012)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (en, 2012) * 1978-07-29 1980-02-13
DK2298769T3 (da) * 2001-02-24 2014-01-20 Boehringer Ingelheim Pharma Xanthinderivater, deres fremstilling og deres anvendelse som lægemiddel
US20030171424A1 (en) * 2002-03-07 2003-09-11 Lin Ai J. Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) * 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
KR101541791B1 (ko) * 2006-05-04 2015-08-04 베링거 인겔하임 인터내셔날 게엠베하 다형태
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
RU2569749C2 (ru) * 2007-08-17 2015-11-27 Бёрингер Ингельхайм Интернациональ Гмбх Производные пурина, предназначенные для применения для лечения заболеваний, связанных с баф (белок-активатор фибробластов)
AR071175A1 (es) 2008-04-03 2010-06-02 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
WO2010018217A2 (en) * 2008-08-15 2010-02-18 Boehringer Ingelheim International Gmbh Organic compounds for wound healing
CN102149407A (zh) 2008-09-10 2011-08-10 贝林格尔.英格海姆国际有限公司 治疗糖尿病和相关病症的组合疗法
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
KR20110103968A (ko) 2008-12-23 2011-09-21 베링거 인겔하임 인터내셔날 게엠베하 유기 화합물의 염 형태
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
KR20190071840A (ko) 2009-11-27 2019-06-24 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
WO2011138421A1 (en) 2010-05-05 2011-11-10 Boehringer Ingelheim International Gmbh Combination therapy
AU2011268940B2 (en) 2010-06-24 2015-05-21 Boehringer Ingelheim International Gmbh Diabetes therapy
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
US8883800B2 (en) 2011-07-15 2014-11-11 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
WO2013171166A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp-4 inhibitor for use in the treatment of sirs and/or sepsis
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
JP6615109B2 (ja) 2014-02-28 2019-12-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｄｐｐ−４阻害薬の医学的使用
JP2019517542A (ja) 2016-06-10 2019-06-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング リナグリプチンおよびメトホルミンの組合せ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1026793A (fr) * 1949-08-02 1953-05-04 American Cyanamid Co Procédé de préparation de sels de pénicilline
NL6803062A (en, 2012) * 1967-03-10 1968-09-11
US3557094A (en) * 1968-01-05 1971-01-19 Pfizer & Co C Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) * 1968-09-28 1971-05-15 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer penicilline

Also Published As

Publication number Publication date
GB1386566A (en) 1975-03-12
JPS4925121A (en, 2012) 1974-03-06
AU5760073A (en) 1975-01-09
BE801588A (fr) 1973-12-28
FR2190414B1 (en, 2012) 1976-07-02
DE2332840A1 (de) 1974-01-17
JPS5512435B2 (en, 2012) 1980-04-02
CH573435A5 (en, 2012) 1976-03-15
FR2190414A1 (en, 2012) 1974-02-01
CS168036B2 (en, 2012) 1976-05-28
PL92969B1 (en, 2012) 1977-04-30
US3925357A (en) 1975-12-09
AU469986B2 (en) 1976-02-26
SE402916B (sv) 1978-07-24
AT325206B (de) 1975-10-10
NL7308048A (en, 2012) 1974-01-03
CA996548A (en) 1976-09-07

Similar Documents

Publication Publication Date Title
FR2190414B1 (en, 2012)
JPS5215008B2 (en, 2012)
FR2167561A1 (en, 2012)
JPS53481B2 (en, 2012)
JPS4883776A (en, 2012)
JPS4893885U (en, 2012)
JPS4889141A (en, 2012)
FR2204404A2 (en, 2012)
JPS4911616A (en, 2012)
JPS4994741A (en, 2012)
FR2173682B3 (en, 2012)
JPS5221322Y2 (en, 2012)
JPS48110771U (en, 2012)
JPS4980607U (en, 2012)
CS153893B1 (en, 2012)
JPS4931382U (en, 2012)
JPS4965099U (en, 2012)
CH584840A5 (en, 2012)
CH583042A5 (en, 2012)
CH568078A5 (en, 2012)
CH566496A5 (en, 2012)
CH570196A5 (en, 2012)
CH624272A4 (en, 2012)
CH605958A5 (en, 2012)
CH590890A5 (en, 2012)